Literature DB >> 6311811

In vitro conversion of proapoprotein A-I to apoprotein A-I. Partial characterization of an extracellular enzyme activity.

C Edelstein, J I Gordon, K Toscas, H F Sims, A W Strauss, A M Scanu.   

Abstract

Previous studies have established that human hepatocellular carcinoma cells (Hep G2) secrete into serum-free medium the pro form of apolipoprotein A-I (proapo-A-I) suggesting that its conversion to mature apo-A-I occurs after secretion. In order to assess the mode and site of proapo-A-I to apo-A-I conversion, we incubated the medium from [3H]proline-labeled Hep G2 cells with either human plasma, serum, lymph, or fractions thereof obtained by density gradient ultracentrifugation. The conversion was monitored by two-dimensional gel electrophoresis and by Edman degradation. Human plasma, serum, or mesenteric lymph all induced proapo-A-I to apo-A-I conversion; this was time dependent, unaffected by the serine protease inhibitor phenylmethylsulfonyl fluoride and inhibited by EDTA. Purified radiolabeled proapo-A-I bound to lymph chylomicrons and plasma high density lipoproteins. The converting enzyme was associated with both of these particles. Activity was also found in the d greater than 1.21-g/ml fraction and may have been derived from high density lipoprotein after displacement by high salts and/or ultracentrifugal force. We conclude that the conversion of proapo-A-I to apo-A-I occurs extracellularly and is probably effected by a metallo-enzyme which may act at the amphiphilic surface of either chylomicrons or high density lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311811

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Maturation of apolipoprotein A-I: unrecognized health benefit or a forgotten rudiment?

Authors:  Dmitri Sviridov
Journal:  J Lipid Res       Date:  2009-03-30       Impact factor: 5.922

2.  Identification of apolipoprotein A-I in BALF as a biomarker of sarcoidosis.

Authors:  Yoshihisa Nukui; Yasunari Miyazaki; Kozo Suhara; Tsukasa Okamoto; Haruhiko Furusawa; Naohiko Inase
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

3.  In vivo metabolism of proapolipoprotein A-I in Tangier disease.

Authors:  D Bojanovski; R E Gregg; L A Zech; M S Meng; C Bishop; R Ronan; H B Brewer
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

4.  Regulation of apoAI processing by procollagen C-proteinase enhancer-2 and bone morphogenetic protein-1.

Authors:  Jian Zhu; Joseph Gardner; Clive R Pullinger; John P Kane; John F Thompson; Omar L Francone
Journal:  J Lipid Res       Date:  2009-02-23       Impact factor: 5.922

5.  Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I.

Authors:  A von Eckardstein; H Funke; A Henke; K Altland; A Benninghoven; G Assmann
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

6.  Characterisation of mRNAs encoding the precursor for human apolipoprotein CI.

Authors:  T J Knott; M E Robertson; L M Priestley; M Urdea; S Wallis; J Scott
Journal:  Nucleic Acids Res       Date:  1984-05-11       Impact factor: 16.971

7.  Comparative in vitro study of the pro-apolipoprotein A-I to apolipoprotein A-I converting activity between normal and Tangier plasma.

Authors:  C Edelstein; J I Gordon; C A Vergani; A L Catapano; V Pietrini; A M Scanu
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

8.  In vivo metabolism of a mutant form of apolipoprotein A-I, apo A-IMilano, associated with familial hypoalphalipoproteinemia.

Authors:  P Roma; R E Gregg; M S Meng; R Ronan; L A Zech; G Franceschini; C R Sirtori; H B Brewer
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

9.  Deletion of the propeptide of apolipoprotein A-I impairs exit of nascent apolipoprotein A-I from the endoplasmic reticulum.

Authors:  R S McLeod; C Robbins; A Burns; Z Yao; P H Pritchard
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

10.  Human apolipoprotein C-II: complete nucleic acid sequence of preapolipoprotein C-II.

Authors:  S S Fojo; S W Law; H B Brewer
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.